Ennumo (pegfilgrastim-pccg)
Biosimilar
- Region
- 🇺🇸 US
- Active substance
- pegfilgrastim-pccg
- Company
- Accord Biopharma Inc.
- Status
- Approved
- FDA approval
- Thu 07 May 2026
- Designations
- Biosimilar
- Application
- BLA761147
- Official record
- www.accessdata.fda.gov
Regulatory milestones
Thu 07 May 2026🇺🇸 FDA approval
FDA approves biosimilar Ennumo (pegfilgrastim-pccg)
Accord Biopharma Inc.; BLA761147; Biosimilar; injectable · source
Follow Ennumo
Get VigiEye Daily: approvals, opinions, safety actions and PDUFA dates every morning.
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.